Corpus ID: 22426466

A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease.

@article{Wirz2017APG,
  title={A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease.},
  author={S. Wirz and G. Molderings},
  journal={Pain physician},
  year={2017},
  volume={20 6},
  pages={
          E849-E861
        }
}
  • S. Wirz, G. Molderings
  • Published 2017
  • Medicine
  • Pain physician
  • Systemic mast cell activation disease (MCAD, a subclass of mastocytosis), which has a prevalence of around 17% (at least in the German population), is characterized by accumulation of genetically altered dysfunctional mast cells with abnormal release of these cells' mediators. Since mast cells affect functions in potentially every organ system, often without causing abnormalities in routine laboratory or radiologic testing, this disease has to be considered routinely in the differential… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 89 REFERENCES
    Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome.
    • 32
    • PDF
    A concise, practical guide to diagnostic assessment for mast cell activation disease
    • 35
    • PDF
    Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
    • 366
    • PDF
    Pharmacological treatment options for mast cell activation disease
    • 24
    • PDF
    Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations.
    • 92
    • PDF
    [Surgical interventions in patients with mast cell activation disease. Aspects relevant for surgery using the example of a cholecystectomy].
    • 3
    Familial Occurrence of Systemic Mast Cell Activation Disease
    • 55
    • PDF
    The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
    • 73
    • PDF